149 related articles for article (PubMed ID: 34532459)
1. Analysis of prognostic factors in 171 patients with myxofibrosarcoma of the trunk and extremities: a cohort study.
Liu H; Zhang X; Zhang S; Yu S
Ann Transl Med; 2021 Aug; 9(16):1322. PubMed ID: 34532459
[TBL] [Abstract][Full Text] [Related]
2. Is the Thickness of the Margin Associated With Local Recurrence and Survival in Patients With Myxofibrosarcoma?
Yurtbay A; Coşkun HS; Say F; Dabak N
Clin Orthop Relat Res; 2023 Nov; 481(11):2125-2136. PubMed ID: 37249339
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
[TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical factors impacting recurrence in myxofibrosarcoma.
Chen W; Ye M; Sun Y; Wei Y; Huang Y
Sci Rep; 2024 Feb; 14(1):3903. PubMed ID: 38365844
[TBL] [Abstract][Full Text] [Related]
5. [Treatment and analysis of prognostic factors of stage Ⅱ and Ⅲ undifferentiated high-grade pleomorphic sarcoma in extremities and trunk].
Zhang XX; Xu LB; Xu SF; Zhao ZG; Fang H; Ma PQ; Liu T; Zhang SG; Yu SJ
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):140-145. PubMed ID: 30862145
[No Abstract] [Full Text] [Related]
6. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
Harati K; Goertz O; Pieper A; Daigeler A; Joneidi-Jafari H; Niggemann H; Stricker I; Lehnhardt M
Oncologist; 2017 Nov; 22(11):1400-1410. PubMed ID: 28739867
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and outcomes of patients with myxofibrosarcoma.
Look Hong NJ; Hornicek FJ; Raskin KA; Yoon SS; Szymonifka J; Yeap B; Chen YL; DeLaney TF; Nielsen GP; Mullen JT
Ann Surg Oncol; 2013 Jan; 20(1):80-6. PubMed ID: 22890594
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation.
Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C
Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139
[TBL] [Abstract][Full Text] [Related]
9. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
10. PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA.
Zumárraga JP; Batista FAR; Baptista AM; Caiero MT; Martino LPR; de Camargo OP
Acta Ortop Bras; 2018; 26(5):320-324. PubMed ID: 30464713
[TBL] [Abstract][Full Text] [Related]
11. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
[TBL] [Abstract][Full Text] [Related]
12. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma.
Billingsley KG; Lewis JJ; Leung DH; Casper ES; Woodruff JM; Brennan MF
Cancer; 1999 Jan; 85(2):389-95. PubMed ID: 10023707
[TBL] [Abstract][Full Text] [Related]
13. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.
Trovik CS; Bauer HC; Alvegård TA; Anderson H; Blomqvist C; Berlin O; Gustafson P; Saeter G; Wallöe A
Eur J Cancer; 2000 Apr; 36(6):710-6. PubMed ID: 10762742
[TBL] [Abstract][Full Text] [Related]
14. Grading in Myxofibrosarcoma of the Extremities Can Predict Survival and Local Control.
Sambri A; Tuzzato G; Spinnato P; De Paolis M; Donati DM; Bianchi G
Oncol Res Treat; 2020; 43(5):189-195. PubMed ID: 32268331
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.
Wei J; Tan YT; Cai YC; Yuan ZY; Yang D; Wang SS; Peng RJ; Teng XY; Liu DG; Shi YX
Chin J Cancer; 2014 Oct; 33(10):492-500. PubMed ID: 25104281
[TBL] [Abstract][Full Text] [Related]
16. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.
Youssef E; Fontanesi J; Mott M; Kraut M; Lucas D; Mekhael H; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):514-9. PubMed ID: 12243830
[TBL] [Abstract][Full Text] [Related]
18. Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement.
Liu Z; Fang Z; Dai T; Zhang C; Sun J; He Y
J Craniomaxillofac Surg; 2015 Jul; 43(6):751-7. PubMed ID: 25958766
[TBL] [Abstract][Full Text] [Related]
19. Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.
Matuschek C; Lehnhardt M; Gerber PA; Poremba C; Hamilton J; Lammering G; Orth K; Budach W; Bojar H; Bölke E; Peiper M
Eur J Med Res; 2014 Feb; 19(1):6. PubMed ID: 24491153
[TBL] [Abstract][Full Text] [Related]
20. Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes.
Stojadinovic A; Yeh A; Brennan MF
J Am Coll Surg; 2002 Apr; 194(4):436-47. PubMed ID: 11949749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]